Assessment of morbidity following regional nodal dissection in the axilla and groin for metastatic melanoma.
Identifieur interne : 000864 ( PubMed/Corpus ); précédent : 000863; suivant : 000865Assessment of morbidity following regional nodal dissection in the axilla and groin for metastatic melanoma.
Auteurs : Jane E. Theodore ; Adam J. Frankel ; Janine M. Thomas ; Andrew P. Barbour ; Gerard J. Bayley ; Christopher P. Allan ; Michael Wagels ; B Mark SmithersSource :
- ANZ journal of surgery [ 1445-2197 ] ; 2017.
English descriptors
- KwdEn :
- Adult, Aged, Axilla, Female, Follow-Up Studies, Forecasting, Humans, Lymph Node Excision (methods), Lymphatic Metastasis, Male, Melanoma (epidemiology), Melanoma (secondary), Melanoma (surgery), Middle Aged, Morbidity (trends), Neoplasm Staging (methods), Queensland (epidemiology), Retrospective Studies, Sentinel Lymph Node Biopsy.
- MESH :
- epidemiology : Melanoma, Queensland.
- methods : Lymph Node Excision, Neoplasm Staging.
- secondary : Melanoma.
- surgery : Melanoma.
- trends : Morbidity.
- Adult, Aged, Axilla, Female, Follow-Up Studies, Forecasting, Humans, Lymphatic Metastasis, Male, Middle Aged, Retrospective Studies, Sentinel Lymph Node Biopsy.
Abstract
This study assessed and compared the morbidity of nodal dissection in the axilla and groin including sentinel lymph node biopsy (SLNB), completion lymph node dissection for a positive SLNB (CLND) and therapeutic lymph node dissection (TLND) with and without adjuvant radiotherapy (RT).
DOI: 10.1111/ans.13526
PubMed: 27102082
Links to Exploration step
pubmed:27102082Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Assessment of morbidity following regional nodal dissection in the axilla and groin for metastatic melanoma.</title><author><name sortKey="Theodore, Jane E" sort="Theodore, Jane E" uniqKey="Theodore J" first="Jane E" last="Theodore">Jane E. Theodore</name><affiliation><nlm:affiliation>The Queensland Melanoma Project, Princess Alexandra Hospital, Brisbane, Queensland, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Frankel, Adam J" sort="Frankel, Adam J" uniqKey="Frankel A" first="Adam J" last="Frankel">Adam J. Frankel</name><affiliation><nlm:affiliation>The Queensland Melanoma Project, Princess Alexandra Hospital, Brisbane, Queensland, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Thomas, Janine M" sort="Thomas, Janine M" uniqKey="Thomas J" first="Janine M" last="Thomas">Janine M. Thomas</name><affiliation><nlm:affiliation>The Queensland Melanoma Project, Princess Alexandra Hospital, Brisbane, Queensland, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Barbour, Andrew P" sort="Barbour, Andrew P" uniqKey="Barbour A" first="Andrew P" last="Barbour">Andrew P. Barbour</name><affiliation><nlm:affiliation>The Queensland Melanoma Project, Princess Alexandra Hospital, Brisbane, Queensland, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Bayley, Gerard J" sort="Bayley, Gerard J" uniqKey="Bayley G" first="Gerard J" last="Bayley">Gerard J. Bayley</name><affiliation><nlm:affiliation>The Queensland Melanoma Project, Princess Alexandra Hospital, Brisbane, Queensland, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Allan, Christopher P" sort="Allan, Christopher P" uniqKey="Allan C" first="Christopher P" last="Allan">Christopher P. Allan</name><affiliation><nlm:affiliation>The Queensland Melanoma Project, Princess Alexandra Hospital, Brisbane, Queensland, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Wagels, Michael" sort="Wagels, Michael" uniqKey="Wagels M" first="Michael" last="Wagels">Michael Wagels</name><affiliation><nlm:affiliation>The Queensland Melanoma Project, Princess Alexandra Hospital, Brisbane, Queensland, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Smithers, B Mark" sort="Smithers, B Mark" uniqKey="Smithers B" first="B Mark" last="Smithers">B Mark Smithers</name><affiliation><nlm:affiliation>The Queensland Melanoma Project, Princess Alexandra Hospital, Brisbane, Queensland, Australia.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2017">2017</date><idno type="RBID">pubmed:27102082</idno><idno type="pmid">27102082</idno><idno type="doi">10.1111/ans.13526</idno><idno type="wicri:Area/PubMed/Corpus">000864</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000864</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Assessment of morbidity following regional nodal dissection in the axilla and groin for metastatic melanoma.</title><author><name sortKey="Theodore, Jane E" sort="Theodore, Jane E" uniqKey="Theodore J" first="Jane E" last="Theodore">Jane E. Theodore</name><affiliation><nlm:affiliation>The Queensland Melanoma Project, Princess Alexandra Hospital, Brisbane, Queensland, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Frankel, Adam J" sort="Frankel, Adam J" uniqKey="Frankel A" first="Adam J" last="Frankel">Adam J. Frankel</name><affiliation><nlm:affiliation>The Queensland Melanoma Project, Princess Alexandra Hospital, Brisbane, Queensland, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Thomas, Janine M" sort="Thomas, Janine M" uniqKey="Thomas J" first="Janine M" last="Thomas">Janine M. Thomas</name><affiliation><nlm:affiliation>The Queensland Melanoma Project, Princess Alexandra Hospital, Brisbane, Queensland, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Barbour, Andrew P" sort="Barbour, Andrew P" uniqKey="Barbour A" first="Andrew P" last="Barbour">Andrew P. Barbour</name><affiliation><nlm:affiliation>The Queensland Melanoma Project, Princess Alexandra Hospital, Brisbane, Queensland, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Bayley, Gerard J" sort="Bayley, Gerard J" uniqKey="Bayley G" first="Gerard J" last="Bayley">Gerard J. Bayley</name><affiliation><nlm:affiliation>The Queensland Melanoma Project, Princess Alexandra Hospital, Brisbane, Queensland, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Allan, Christopher P" sort="Allan, Christopher P" uniqKey="Allan C" first="Christopher P" last="Allan">Christopher P. Allan</name><affiliation><nlm:affiliation>The Queensland Melanoma Project, Princess Alexandra Hospital, Brisbane, Queensland, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Wagels, Michael" sort="Wagels, Michael" uniqKey="Wagels M" first="Michael" last="Wagels">Michael Wagels</name><affiliation><nlm:affiliation>The Queensland Melanoma Project, Princess Alexandra Hospital, Brisbane, Queensland, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Smithers, B Mark" sort="Smithers, B Mark" uniqKey="Smithers B" first="B Mark" last="Smithers">B Mark Smithers</name><affiliation><nlm:affiliation>The Queensland Melanoma Project, Princess Alexandra Hospital, Brisbane, Queensland, Australia.</nlm:affiliation></affiliation></author></analytic><series><title level="j">ANZ journal of surgery</title><idno type="eISSN">1445-2197</idno><imprint><date when="2017" type="published">2017</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Aged</term><term>Axilla</term><term>Female</term><term>Follow-Up Studies</term><term>Forecasting</term><term>Humans</term><term>Lymph Node Excision (methods)</term><term>Lymphatic Metastasis</term><term>Male</term><term>Melanoma (epidemiology)</term><term>Melanoma (secondary)</term><term>Melanoma (surgery)</term><term>Middle Aged</term><term>Morbidity (trends)</term><term>Neoplasm Staging (methods)</term><term>Queensland (epidemiology)</term><term>Retrospective Studies</term><term>Sentinel Lymph Node Biopsy</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Melanoma</term><term>Queensland</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Lymph Node Excision</term><term>Neoplasm Staging</term></keywords><keywords scheme="MESH" qualifier="secondary" xml:lang="en"><term>Melanoma</term></keywords><keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Melanoma</term></keywords><keywords scheme="MESH" qualifier="trends" xml:lang="en"><term>Morbidity</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Axilla</term><term>Female</term><term>Follow-Up Studies</term><term>Forecasting</term><term>Humans</term><term>Lymphatic Metastasis</term><term>Male</term><term>Middle Aged</term><term>Retrospective Studies</term><term>Sentinel Lymph Node Biopsy</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">This study assessed and compared the morbidity of nodal dissection in the axilla and groin including sentinel lymph node biopsy (SLNB), completion lymph node dissection for a positive SLNB (CLND) and therapeutic lymph node dissection (TLND) with and without adjuvant radiotherapy (RT).</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27102082</PMID><DateCreated><Year>2016</Year><Month>04</Month><Day>22</Day></DateCreated><DateCompleted><Year>2017</Year><Month>02</Month><Day>28</Day></DateCompleted><DateRevised><Year>2017</Year><Month>08</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1445-2197</ISSN><JournalIssue CitedMedium="Internet"><Volume>87</Volume><Issue>1-2</Issue><PubDate><Year>2017</Year><Month>Jan</Month></PubDate></JournalIssue><Title>ANZ journal of surgery</Title><ISOAbbreviation>ANZ J Surg</ISOAbbreviation></Journal><ArticleTitle>Assessment of morbidity following regional nodal dissection in the axilla and groin for metastatic melanoma.</ArticleTitle><Pagination><MedlinePgn>44-48</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/ans.13526</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">This study assessed and compared the morbidity of nodal dissection in the axilla and groin including sentinel lymph node biopsy (SLNB), completion lymph node dissection for a positive SLNB (CLND) and therapeutic lymph node dissection (TLND) with and without adjuvant radiotherapy (RT).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Patients who had nodal dissection in the axilla or groin for cutaneous melanoma over an 18-year period (1995-2013) were prospectively documented on a database. The median follow-up was nearly 3 years. Early complications and clinically relevant lymphoedema were retrospectively analysed to assess the incidence and differences between the region and type of nodal surgery.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Included were 1521 patients following nodal dissection in the axilla (916 patients) and groin (605 patients). Less early complications occurred following SLNB in the axilla compared with the groin (5% versus 14%, P = 0.0001). Early complications were similar for CLND and TLND in the groin (49% versus 43%, P = 0.879) and axilla (28% versus 33%, P = 0.607). Moderate to severe lymphoedema rates were similar following axillary SLNB and CLND (6% versus 8%, P = 0.407). The lymphoedema rate for groin SLNB was lower than CLND (10% versus 20%, P = 0.063). No significant difference in lymphoedema rates followed CLND and TLND in each region. Following TLND, RT increased lymphoedema rates.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Morbidity may occur following SLNB with the groin having a higher rate of early complications and lymphoedema compared with the axilla. The morbidity following CLND and TLND were similar. Lymphoedema rates were increased following RT.</AbstractText><CopyrightInformation>© 2016 Royal Australasian College of Surgeons.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Theodore</LastName><ForeName>Jane E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>The Queensland Melanoma Project, Princess Alexandra Hospital, Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The University of Queensland, Mater Health Services, Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frankel</LastName><ForeName>Adam J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>The Queensland Melanoma Project, Princess Alexandra Hospital, Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thomas</LastName><ForeName>Janine M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>The Queensland Melanoma Project, Princess Alexandra Hospital, Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Mater Research Institute, Mater Health Services, Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barbour</LastName><ForeName>Andrew P</ForeName><Initials>AP</Initials><AffiliationInfo><Affiliation>The Queensland Melanoma Project, Princess Alexandra Hospital, Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Princess Alexandra Hospital, The University of Queensland, Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bayley</LastName><ForeName>Gerard J</ForeName><Initials>GJ</Initials><AffiliationInfo><Affiliation>The Queensland Melanoma Project, Princess Alexandra Hospital, Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Allan</LastName><ForeName>Christopher P</ForeName><Initials>CP</Initials><AffiliationInfo><Affiliation>The Queensland Melanoma Project, Princess Alexandra Hospital, Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The University of Queensland, Mater Health Services, Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wagels</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>The Queensland Melanoma Project, Princess Alexandra Hospital, Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Princess Alexandra Hospital, The University of Queensland, Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smithers</LastName><ForeName>B Mark</ForeName><Initials>BM</Initials><AffiliationInfo><Affiliation>The Queensland Melanoma Project, Princess Alexandra Hospital, Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Princess Alexandra Hospital, The University of Queensland, Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Mater Research Institute, Mater Health Services, Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>04</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Australia</Country><MedlineTA>ANZ J Surg</MedlineTA><NlmUniqueID>101086634</NlmUniqueID><ISSNLinking>1445-1433</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Disease" UI="C562393">Melanoma, Cutaneous Malignant</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001365" MajorTopicYN="N">Axilla</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005544" MajorTopicYN="Y">Forecasting</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008197" MajorTopicYN="N">Lymph Node Excision</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008207" MajorTopicYN="N">Lymphatic Metastasis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008545" MajorTopicYN="N">Melanoma</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000556" MajorTopicYN="N">secondary</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009017" MajorTopicYN="N">Morbidity</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009367" MajorTopicYN="N">Neoplasm Staging</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011793" MajorTopicYN="N">Queensland</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D021701" MajorTopicYN="N">Sentinel Lymph Node Biopsy</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">general surgery</Keyword><Keyword MajorTopicYN="N">plastic and reconstructive surgery</Keyword><Keyword MajorTopicYN="N">surgical oncology</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>11</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>02</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>02</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>4</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>3</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>4</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27102082</ArticleId><ArticleId IdType="doi">10.1111/ans.13526</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000864 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000864 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:27102082
|texte= Assessment of morbidity following regional nodal dissection in the axilla and groin for metastatic melanoma.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:27102082" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |